[1]
(a)Rasouli, H.; Hosseini-Ghazvini, S.M-B.; Adibi, H.; Khodarahmi, R. Differential α-amylase/α-glucosidase inhibitory activities of plant-derived phenolic compounds: A virtual screening perspective for the treatment of obesity and diabetes. Food Funct., 2017, 8, 1942-1954.
(b)Rasouli, H.; Farzaei, M.H.; Khodarahmi, R. Polyphenols and their benefits: A review. Int. J. Food Prop., 2017, 20, 1700-1741.
(c)Siah, M.; Farzaei, M.H.; Ashrafi-Kooshk, M.R.; Adibi, H.; Arab, S.S.; Rashidi, M.R.; Khodarahmi, R. Inhibition of guinea pig aldehyde oxidase activity by different flavonoid compounds: An in vitro study. Bioorg. Chem., 2016, 64, 74-84.
[2]
(a)Aggarwal, B.B.; Kumar, A.; Bharti, A.C. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res., 2003, 23, 363-398.
(b)Sahu, A.; Kasoju, N.; Bora, U. Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules, 2008, 9, 2905-2912.
[3]
Aggarwal, B.B.; Bhatt, I.D.; Ichikawa, H.; Ahn, K.S.; Sethi, G.; Sandur, S.K.; Natarajan, C.; Seeram, N.; Shishodia, S. Curcumin-Biological and Medicinal Properties.Turmeric: The Genus Curcuma; Ravindran, P.N.; Babu, K.N.; Sivaraman, K., Eds.; CRC Press: Boca Raton, FL, 2006, pp. 297-368.
(b) Leung, M.H.; Kee, T.W. Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen. Langmuir, 2009, 25, 5773-5777.
[4]
Hsu, C-H.; Cheng, A-L. Clinical studies with curcumin.The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease; Aggarwal, B.B.; Surh, Y-J.; Shishodia, S., Eds.; Springer: Berlin, Germany, 2007, pp. 471-480.
(b)Hsieh, C-Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res., 2001, 21, 2895-2900.
[5]
Krishnakumar, I.; Ravi, A.; Kumar, D.; Kuttan, R.; Maliakel, B. An enhanced bioavailable formulation of curcumin using fenugreek-derived soluble dietary fibre. J. Funct. Foods, 2012, 4, 348-357.
[6]
Wang, Y-J.; Pan, M-H.; Cheng, A-L.; Lin, L-I.; Ho, Y-S.; Hsieh, C-Y.; Lin, J-K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal., 1997, 15, 1867-1876.
[7]
Liang, G.; Shao, L.; Wang, Y.; Zhao, C.; Chu, Y.; Xiao, J.; Zhao, Y.; Li, X.; Yang, S. Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents. Bioorg. Med. Chem., 2009, 17, 2623-2631.
[8]
(a)Canamares, M.; Garcia-Ramos, J.; Sanchez-Cortes, S. Degradation of curcumin dye in aqueous solution and on Ag nanoparticles studied by ultraviolet-visible absorption and surface-enhanced Raman spectroscopy. Appl. Spectrosc., 2006, 60, 1386-1391.
(b)Mohanty, C.; Sahoo, S.K. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials, 2010, 31, 6597-6611.
[9]
Shahlaei, M.; Rahimi, B.; Nowroozi, A.; Ashrafi-Kooshk, M.R.; Sadrjavadi, K.; Khodarahmi, R. Exploring binding properties of sertraline with human serum albumin: Combination of spectroscopic and molecular modeling studies. Chem. Biol. Interact., 2015, 242, 235-246.
[10]
(a)Kunwar, A.; Barik, A.; Pandey, R.; Priyadarsini, K.I. Transport of liposomal and albumin loaded curcumin to living cells: An absorption and fluorescence spectroscopic study. Biochim. Biophys. Acta, 2006, 1760, 1513-1520.
(b)Mohammadi, F.; Bordbar, A-K.; Divsalar, A.; Mohammadi, K.; Saboury, A.A. Interaction of curcumin and diacetylcurcumin with the lipocalin member β-lactoglobuli. Protein J., 2009, 28, 117-123.
(c)Peters, T., Jr Serum albumin. In: Advances in Protein Chemistry; Anfinsen, C.B.; Edsall, J.T.; Richards, F.M., Eds.; Elsevier: Amsterdam, 1985; Vol. 37, pp. 161-245.
(d)Sneharani, A.H.; Karakkat, J.V.; Singh, S.A.; Rao, A.A. Interaction of curcumin with β-lactoglobulin stability, spectroscopic analysis, and molecular modeling of the complex. J. Agric. Food Chem., 2010, 58, 11130-11139.
[11]
(a)Zamboni, W.C. Liposomal, nanoparticle, and conjugated formulations of anticancer agents. Clin. Cancer Res., 2005, 11, 8230-8234.
(b)Portnaya, I.; Cogan, U.; Livney, Y.D.; Ramon, O.; Shimoni, K.; Rosenberg, M.; Danino, D. Micellization of bovine β-casein studied by isothermal titration microcalorimetry and cryogenic transmission electron microscopy. J. Agric. Food Chem., 2006, 54, 5555-5561.
[12]
Mohammadi, F.; Bordbar, A-K.; Divsalar, A.; Mohammadi, K.; Saboury, A.A. Analysis of binding interaction of curcumin and diacetylcurcumin with human and bovine serum albumin using fluorescence and circular dichroism spectroscopy. Protein J., 2009, 28, 189-196.
[13]
(a) Mitra, S.P. Binding and stability of curcumin in presence of bovine serum albumin. J. Surf. Sci. Technol, 2007, 23, 91.
(b) Esmaili, M.; Ghaffari, S.M.; Moosavi-Movahedi, Z.; Atri, M.S.; Sharifizadeh, A.; Farhadi, M.; Yousefi, R.; Chobert, J-M.; Haertlé, T.; Moosavi-Movahedi, A.A. Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application. J. Lebensm. Wiss. Technol., 2011, 44, 2166-2172.
[14]
(a) Kulmyrzaev, A.A.; Levieux, D.; Dufour, É. Front-face fluorescence spectroscopy allows the characterization of mild heat treatments applied to milk. Relations with the denaturation of milk proteins. J. Agric. Food Chem., 2005, 53, 502-507.
(b) Tayyab, S.; Haq, S.K.; Aziz, M.A.; Khan, M.M.; Muzammil, S. Effect of lysine modification on the conformation and indomethacin binding properties of human serum albumin. Int. J. Biol. Macromol., 1999, 26, 173-180.
[15]
(a) Mirzaee, F.; Kooshk, M.R.A.; Rezaei-Tavirani, M.; Khodarahmi, R. Protective effects of accompanying proteins on light-and water-mediated degradation of Curcumin. J. Paramed. Sci., 2013, 5.
(b) Kooshk, M.R.A.; Mansouri, K.; Nadi, M.M.; Khodarahmi, S.; Khodarahmi, R. In vitro anti-cancer activity of native curcumin and “Protein-Curcumin” systems: A perspective on drug-delivery application. J. Rep. Pharm. Sci., 2013, 2, 66-74.
[16]
Lozano, J.M.; Giraldo, G.I.; Romero, C.M. An improved method for isolation of β-lactoglobulin. Int. Dairy J., 2008, 18, 55-63.
[17]
(a) Lawal, O.; Adebowale, K. The acylated protein derivatives of Canavalia ensiformis (jack bean): A study of functional characteristics. LWT-Food. Sci. Tech., 2006, 39, 918-929.
(b) Jangholi, A.; Ashrafi-Kooshk, M.R.; Arab, S.S.; Riazi, G.; Mokhtari, F.; Poorebrahim, M.; Mahdiuni, H.; Kurganov, B.I.; Moosavi-Movahedi, A.A.; Khodarahmi, R. Appraisal of role of the polyanionic inducer length on amyloid formation by 412-residue 1N4R Tau protein: A comparative study. Arch. Biochem. Biophys., 2016, 609, 1-19.
[18]
Snyder, S.L.; Sobocinski, P.Z. An improved 2, 4, 6-trinitrobenzenesulfonic acid method for the determination of amines. Anal. Biochem., 1975, 64, 284-288.
[19]
Hudson, E.A.; de Paula, H.M.C.; Ferreira, G.M.D.; Ferreira, G.M.D.; do Carmo Hespanhol, M.; da Silva, L.H.M.; Pires, A.C.S. Thermodynamic and kinetic analyses of curcumin and bovine serum albumin binding. Food Chem., 2018, 242, 505-512.
[20]
Lakowicz, J. Principles of Fluorescent Spectroscopy, 2nd ed; Kluwer Academic/Plenum Press: New York, 1999.
[21]
Moradi, N.; Ashrafi-Kooshk, M.R.; Ghobadi, S.; Shahlaei, M.; Khodarahmi, R. Spectroscopic study of drug-binding characteristics of unmodified and pNPA-based acetylated human serum albumin: Does esterase activity affect microenvironment of drug binding sites on the protein? J. Lumin., 2015, 160, 351-361.
[22]
Goupy, P.; Dufour, C.; Loonis, M.; Dangles, O. Quantitative kinetic analysis of hydrogen transfer reactions from dietary polyphenols to the DPPH radical. J. Agric. Food Chem., 2003, 51, 615-622.
[23]
Shen, L.; Ji, H-F. Low stability remedies the low bioavailability of curcumin. Trends Mol. Med., 2012, 18, 363-364.
[24]
Mondal, S.; Ghosh, S.; Moulik, S.P. Stability of curcumin in different solvent and solution media: UV-visible and steady-state fluorescence spectral study. J. Photochem. Photobiol., 2016, 158, 212-218.
[25]
Nadi, M.M.; Kooshk, M.R.A.; Mansouri, K.; Ghadami, S.A.; Amani, M.; Ghobadi, S.; Khodarahmi, R. Comparative spectroscopic studies on curcumin stabilization by association to bovine serum albumin and casein: A perspective on drug-delivery application. Int. J. Food Prop., 2015, 18, 638-659.
[26]
Leung, M.H.; Colangelo, H.; Kee, T.W. Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. Langmuir, 2008, 24, 5672-5675.
[27]
Möller, M.; Denicola, A. Study of protein‐ligand binding by fluorescence. Biochem. Mol. Biol. Educ., 2002, 30, 309-312.
[28]
Sahoo, B.K.; Ghosh, K.S.; Dasgupta, S. Molecular interactions of isoxazolcurcumin with human serum albumin: Spectroscopic and molecular modeling studies. Biopolymers, 2009, 91, 108-119.
[29]
Goodsell, D.S.; Olson, A.J. Automated docking of substrates to proteins by simulated annealing. Proteins, 1990, 8, 195-202.
[30]
Chen, T.; Cao, H.; Zhu, S.; Lu, Y.; Shang, Y.; Wang, M.; Tang, Y.; Zhu, L. Investigation of the binding of Salvianolic acid B to human serum albumin and the effect of metal ions on the binding. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2011, 81, 645-652.
[31]
Li, M.; Ma, Y.; Ngadi, M.O. Binding of curcumin to β-lactoglobulin and its effect on antioxidant characteristics of curcumin. Food Chem., 2013, 141, 1504-1511.
[32]
Ross, P.D.; Subramanian, S. Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry, 1981, 20, 3096-3102.
[33]
(a) Khodarahmi, R.; Karimi, S.A.; Kooshk, M.R.A.; Ghadami, S.A.; Ghobadi, S.; Amani, M. Comparative spectroscopic studies on drug binding characteristics and protein surface hydrophobicity of native and modified forms of bovine serum albumin: Possible relevance to change in protein structure/function upon non-enzymatic glycation. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2012, 89, 177-186.
(b) Hu, T-Y.; Liu, C-L.; Chen, J-Y.; Hu, M-L. Curcumin ameliorates methylglyoxal-induced alterations of cellular morphology and hyperpermeability in human umbilical vein endothelial cells. J. Funct. Foods, 2013, 5, 745-754.
[34]
Litwinienko, G.; Ingold, K. Abnormal solvent effects on hydrogen atom abstraction. 2. Resolution of the curcumin antioxidant controversy. The role of sequential proton loss electron transfer. J. Org. Chem., 2004, 69, 5888-5896.
[35]
Yang, M.; Wu, Y.; Li, J.; Zhou, H.; Wang, X. Binding of curcumin with bovine serum albumin in the presence of ι-carrageenan and implications on the stability and antioxidant activity of curcumin. J. Agric. Food Chem., 2013, 61, 7150-7155.
[36]
Blasius, R.; Duvoix, A.; Morceau, F.; Schnekenburger, M.; Delhalle, S.; Henry, E.; Dicato, M.; Diederich, M. curcumin stability and its effect on glutathione S‐transferase P1‐1 mRNA expression in K562 cells. Ann. N. Y. Acad. Sci., 2004, 1030, 442-448.
[37]
Nishikawa, H.; Tsutsumi, J.; Kitani, S. Anti-inflammatory and anti-oxidative effect of curcumin in connective tissue type mast cell. J. Funct. Foods, 2013, 5, 763-772.
[38]
(a) Azmi, A.S.; Bhat, S.H.; Hanif, S.; Hadi, S. Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: A putative mechanism for anticancer properties. FEBS Lett., 2006, 580, 533-538.
(b) Elbling, L.; Weiss, R-M.; Teufelhofer, O.; Uhl, M.; Knasmueller, S.; Schulte-Hermann, R.; Berger, W.; Micksche, M. Green tea extract and (–)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J., 2005, 19, 807-809.
[39]
Agullo, G.; Gamet-Payrastre, L.; Fernandez, Y.; Anciaux, N.; Demigné, C.; Rémésy, C. Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells). Cancer Lett., 1996, 105, 61-70.